Molecure achieved key milestones in the development of its innovative therapies in 2024 and plans to accelerate research and ...

Preliminary efficacy data from Phase 1/2 dose expansion cohort show durable responses and tumor shrinkage in a PD-(L)1 resistant “hot” tumor ...

Clinical trials start with early discovery and ongoing research. After approval by the FDA, the research goes through the following phases. Patient participants are essential to clinical trials. Ask ...

Early results from Wave's ongoing DMD Phase II trial saw a decline in muscle necrosis and inflammation in the trial ...

BDC-3042 is a proprietary agonist antibody that targets dectin-2, an immune-activating receptor expressed by tumor-associated macrophages (TAMs). This single-agent, dose-escalation Phase 1 clinical ...

The phase III trial COURAGE-ALS of investigational reldesemtiv, a fast skeletal troponin activator, did not meet its primary ...

Evaxion will present new biomarker and immune data obtained from the ongoing phase 2 trial. These will further add to EVX-01’s already strong clinical data package.

Because of this, clinical research is even more regimented and regulated. "Clinical research is unique in that clinical trials have specific, designated phases," Dr. Saratsis explained. "A clinical ...

Differential Response Between African Americans and Non-African Americans with Resistant Hypertension to MANP, a Novel ...

Shanghai Ark Biopharmaceutical Co., Ltd. ('ArkBio') today announced the successful completion of the Phase III clinical study ...

Chronic rhinosinusitis with nasal polyps presents a substantial clinical burden, affecting nasal airflow, olfactory function, and quality of life. Epithelial barrier dysfunction and type 2 ...

Researchers from Liverpool School of Tropical Medicine (LSTM) have completed a Phase I clinical trial for a new oral treatment for snakebite.